@article{13d2e123dc6e41298caf886daa10ade6,
title = "25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions",
keywords = "Adjuvant, Adverse events, AJCC, Biomarkers, BRAF, Checkpoint, Dabrafenib, Immunotherapy, Interferon, Ipilimumab, Lymph node, Melanoma, Nivolumab, Overall survival, PD-L1, Pembrolizumab, Recurrence-free survival, Resected, Targeted therapy, Toxicity, Trametinib",
author = "Truong, {Thach Giao} and Kennedy, {Lucy Boyce} and Patel, {Sapna P.}",
year = "2022",
month = apr,
doi = "10.1007/s11912-022-01232-0",
language = "English (US)",
volume = "24",
pages = "533--542",
journal = "Current oncology reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "4",
}